Parnax Lab Ltd (506128)

Parnax Lab Ltd has announced the notice of book closure and cut-off date for its upcoming 44th Annual General Meeting (AGM) scheduled for September 29, 2026. The share transfer books and Register of Members will remain closed from September 23, 2026, to September 29, 2026. The company has fixed September 22, 2026, as the record date (cut-off date) to determine shareholder voting eligibility. Remote e-voting will take place from September 26, 2026 (09:00 AM) to September 28, 2026 (05:00 PM).

• 44th Annual General Meeting scheduled for September 29, 2026
• Share transfer books and Register of Members closed from September 23 to September 29, 2026
• Record date (cut-off date) for e-voting fixed as September 22, 2026
• E-voting period commences September 26, 2026 (09:00 AM) and ends September 28, 2026 (05:00 PM)

Parnax Lab Ltd held a Board Meeting on August 26, 2026, where it reviewed and took note of the Secretarial Auditor's Report. The Board approved the revised Directors' Report along with relevant attachments for the financial year ended March 31, 2026. All other matters and details previously approved in the board meeting held on August 14, 2026, remain unchanged.

• Board meeting conducted on August 26, 2026 between 03:30 PM and 04:00 PM
• Took note of Secretarial Auditor's Report for FY ended March 31, 2026
• Approved revised Directors' Report and attachments for FY ended March 31, 2026
• Confirmed all other items from the prior August 14, 2026 meeting remain unchanged

Parnax Lab Limited announced that its Board has granted in-principle approval for appointing M/s. Ladha Singhal & Associates, Chartered Accountants, as Statutory Auditors for a five-year term from the upcoming AGM until 2031. This appointment replaces retiring auditors M/s. C N Patel & Co in compliance with mandatory auditor rotation rules under Section 139 of the Companies Act, 2013. The appointment is subject to approval by shareholders at the 44th Annual General Meeting on September 29, 2026. Alongside this, the Board approved Q1 (June 30, 2026) consolidated net profit of Rs 42.50 lakhs with basic EPS of Rs 0.37.

• Appointment of M/s. Ladha Singhal & Associates as Statutory Auditors for a 5-year term (ensuing AGM till 2031 AGM)
• Replaces retiring auditors M/s. C N Patel & Co upon expiry of their statutory term under Section 139
• 44th Annual General Meeting convened for September 29, 2026 via VC/OAVM
• Consolidated Net Profit of Rs 42.50 lakhs reported for the quarter ended June 30, 2026

Prakash Mahasukhlal Shah, a promoter of Parnax Lab Ltd, acquired 3,61,872 shares (3.15% stake) from another promoter, Ila B. Shah, via an off-market gift on July 20, 2026. This transaction is an inter-se transfer within the promoter group, resulting in no change to the total promoter holding of 72.3%. The acquisition was conducted under the exemption provided by Regulation 10(1)(a)(ii) of SEBI (SAST) Regulations. This represents a routine internal restructuring of shares within the promoter family.

• 3,61,872 equity shares transferred via off-market gift
• 3.15% of the total share capital involved in the inter-se transfer
• Acquirer's individual stake increased from 10.46% to 13.61%
• Seller's individual stake decreased from 11.86% to 8.71%
• Total promoter group holding remains unchanged at 72.3%

Prakash Mahasukhlal Shah, a promoter of Parnax Lab Ltd, acquired 3,61,872 equity shares (3.15% stake) from another promoter, Ila B. Shah, on July 20, 2026. The transaction was conducted as an off-market inter-se transfer by way of a gift, meaning no cash was exchanged. Consequently, the total promoter group holding remains unchanged at 72.3%, while the individual stake of Prakash Shah increased from 10.46% to 13.61%. This filing is a regulatory requirement under SEBI (SAST) Regulations to report exempt acquisitions.

• 3,61,872 equity shares transferred between promoters via an off-market gift
• 3.15% of the total share capital was involved in this inter-se transaction
• Acquirer Prakash Mahasukhlal Shah's individual stake rose from 10.46% to 13.61%
• Seller Ila B. Shah's individual stake decreased from 11.86% to 8.71%
• Total promoter group holding remains constant at 72.3% post-transaction

Mihir Prakash Shah, a member of the promoter group, acquired 3,77,355 equity shares (3.29% stake) from Baiju Mahasukhlal Shah via an inter-se gift on July 21, 2026. This off-market transaction was conducted for zero consideration and does not change the aggregate promoter group holding, which remains at 72.3%. The filing is a procedural disclosure under SEBI (SAST) Regulation 10(7) to maintain exemption from open offer requirements.

• Transfer of 3,77,355 equity shares between two promoter group members
• Acquirer's individual stake increased from 9.94% to 13.22%
• Seller's individual stake decreased from 11.57% to 8.29%
• Transaction executed on July 21, 2026, as a gift with no cash consideration
• Overall promoter group holding remains unchanged at 72.3%

Mihir Prakash Shah, a member of the promoter group, has acquired 3,77,355 equity shares (3.29% stake) from another promoter, Baiju Shah, through an inter-se gift transfer. The transaction took place off-market on July 21, 2026, and does not change the aggregate promoter holding of the company, which remains at 72.3%. This filing is a formal report to SEBI under Regulation 10(7) of the SAST Regulations, confirming the completion of the procedural requirements for the exemption from an open offer.

• Transfer of 3,77,355 equity shares between two promoters via an off-market gift
• Acquisition represents 3.29% of the total share capital of the company
• Mihir Prakash Shah's individual stake increased from 9.94% to 13.22%
• Baiju Shah's individual stake decreased from 11.57% to 8.29%
• Total promoter and promoter group shareholding remains unchanged post-transaction

Shareholders of Parnax Lab Ltd have approved the re-appointment of Mr. Yogesh K. Varia as a Non-Executive Independent Director via a special resolution. The second term spans five years, effective from May 28, 2026, to May 27, 2031. Mr. Varia brings over 40 years of experience in pharmaceutical and cosmetics manufacturing to the board. This procedural move ensures continuity in governance for the company, which currently holds a market capitalization of Rs 154 Cr and TTM revenue of Rs 249 Cr.

• Re-appointment for a second term of 5 consecutive years approved via Postal Ballot.
• New term effective from May 28, 2026, through May 27, 2031.
• Director brings 40+ years of experience in pharmaceutical and cosmetics manufacturing.
• Director holds Nil shares in the company as of the Postal Ballot notice date.
• Special Resolution passed following a remote e-voting period from July 10 to August 8, 2026.

Parnax Lab Ltd has scheduled a board meeting on August 14, 2026, to consider and approve its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The company enters this quarter following a FY26 performance that saw revenue reach Rs 249 Cr but with operating margins compressing to 11% from 14% in the previous year. The trading window for insiders has been closed since July 1, 2026, in compliance with SEBI regulations. Investors will be monitoring if the company can maintain its revenue growth trajectory, which saw a 30% increase in Q4 FY26 compared to Q1 FY25.

• Board meeting to be held on August 14, 2026, for Q1 FY27 results approval
• Trading window for equity shares closed from July 1, 2026, until 48 hours post-results
• Company reported TTM revenue of Rs 249 Cr and PAT of Rs 12 Cr as of March 2026
• Operating profit margin stood at 11.0% for the trailing twelve months
• Debt-to-equity ratio remains relatively high at 0.87 with Rs 83 Cr in debt